Drug Type Small molecule drug |
Synonyms NB 001(Yongzhan Pharmaceutical), NB-001(Yongzhan Pharmaceutical) |
Target |
Mechanism ADCY1 inhibitors(Brain adenylate cyclase 1 inhibitors), Cell membrane modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H20N6O |
InChIKeyCVPTTZZCRDVGSU-UHFFFAOYSA-N |
CAS Registry686301-48-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | Phase 1 | CN | 08 Jul 2019 | |
Neuralgia | Preclinical | IN | 12 Jan 2011 |